10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 107 filers reported holding 10X GENOMICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 2.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,212,103 | -81.1% | 525,044 | -63.6% | 0.25% | -79.0% |
Q1 2024 | $54,064,227 | -33.2% | 1,440,560 | -0.4% | 1.20% | -38.8% |
Q4 2023 | $80,949,066 | +160.6% | 1,446,552 | +92.1% | 1.97% | +188.7% |
Q3 2023 | $31,066,619 | -34.4% | 753,130 | -11.2% | 0.68% | -20.3% |
Q2 2023 | $47,342,276 | -0.1% | 847,820 | -0.2% | 0.86% | +29.3% |
Q1 2023 | $47,379,339 | +32.3% | 849,244 | -13.6% | 0.66% | +37.1% |
Q4 2022 | $35,813,847 | +25.1% | 982,817 | -2.3% | 0.48% | +15.6% |
Q3 2022 | $28,637,000 | +469.9% | 1,005,542 | +2395.1% | 0.42% | +403.6% |
Q3 2020 | $5,025,000 | -29.7% | 40,300 | -49.6% | 0.08% | -37.6% |
Q2 2020 | $7,145,000 | -18.1% | 80,000 | -42.9% | 0.13% | -37.3% |
Q1 2020 | $8,725,000 | – | 140,000 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |